J&J and Protagonist’s icotrokinra scores in Phase IIb UC study

Submitted by admin on March 11, 2025 - 11:13am

Source:

Clinical Trials Arena

News Tags:

Headline:

snippet:

GlobalData predicts that icotrokinra will reach blockbuster status in 2029, with the drug forecast to generate sales of $2.19bn in 2030.

Search form